JP2008534438A5 - - Google Patents

Download PDF

Info

Publication number
JP2008534438A5
JP2008534438A5 JP2007551316A JP2007551316A JP2008534438A5 JP 2008534438 A5 JP2008534438 A5 JP 2008534438A5 JP 2007551316 A JP2007551316 A JP 2007551316A JP 2007551316 A JP2007551316 A JP 2007551316A JP 2008534438 A5 JP2008534438 A5 JP 2008534438A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
proton pump
pump inhibitor
inhibitor
outer coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007551316A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008534438A (ja
Filing date
Publication date
Priority claimed from US11/328,259 external-priority patent/US20060165797A1/en
Application filed filed Critical
Publication of JP2008534438A publication Critical patent/JP2008534438A/ja
Publication of JP2008534438A5 publication Critical patent/JP2008534438A5/ja
Pending legal-status Critical Current

Links

JP2007551316A 2005-01-12 2006-01-11 胃腸障害を処置するための剤形 Pending JP2008534438A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64313705P 2005-01-12 2005-01-12
US11/328,259 US20060165797A1 (en) 2005-01-12 2006-01-10 Dosage form for treating gastrointestinal disorders
PCT/US2006/000782 WO2006076338A2 (en) 2005-01-12 2006-01-11 Dosage form for treating gastrointestinal disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008307505A Division JP2009102335A (ja) 2005-01-12 2008-12-02 胃腸障害を処置するための剤形

Publications (2)

Publication Number Publication Date
JP2008534438A JP2008534438A (ja) 2008-08-28
JP2008534438A5 true JP2008534438A5 (enExample) 2009-01-29

Family

ID=36697056

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007551316A Pending JP2008534438A (ja) 2005-01-12 2006-01-11 胃腸障害を処置するための剤形
JP2008307505A Pending JP2009102335A (ja) 2005-01-12 2008-12-02 胃腸障害を処置するための剤形

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008307505A Pending JP2009102335A (ja) 2005-01-12 2008-12-02 胃腸障害を処置するための剤形

Country Status (8)

Country Link
US (1) US20060165797A1 (enExample)
JP (2) JP2008534438A (enExample)
AU (1) AU2006205087A1 (enExample)
BR (1) BRPI0606333A2 (enExample)
CA (1) CA2592542A1 (enExample)
IL (1) IL184456A0 (enExample)
NO (1) NO20073716L (enExample)
WO (1) WO2006076338A2 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
AR051654A1 (es) * 2004-11-04 2007-01-31 Astrazeneca Ab Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones
JPWO2007074909A1 (ja) * 2005-12-28 2009-06-04 武田薬品工業株式会社 放出制御固形製剤
MY151470A (en) * 2005-12-28 2014-05-30 Takeda Pharmaceutical Controlled release solid preparation
WO2008043740A1 (en) * 2006-10-10 2008-04-17 Novartis Ag Use of lansoprazole for the treatment of frequent heartburn
CN101600419B (zh) * 2006-12-22 2012-05-09 株式会社柳韩洋行 含有瑞伐拉赞的固体分散体以及其制备方法
US20080194307A1 (en) * 2007-02-13 2008-08-14 Jeff Sanger Sports-based game of chance
US20090280175A1 (en) * 2008-05-09 2009-11-12 Ishwar Chauhan Multilayer Proton Pump Inhibitor Tablets
US20090280173A1 (en) * 2008-05-09 2009-11-12 Ishwar Chauhan Multilayer Omeprazole Tablets
EP2364145A4 (en) * 2008-05-30 2013-11-13 Pozen Inc GALENIC FORMS FOR RAPID AND EXTENDED ELEVATION OF GASTRIC PH
AU2009290712A1 (en) 2008-09-09 2010-03-18 Astrazeneca Ab Method for delivering a pharmaceutical composition to patient in need thereof
WO2010138441A1 (en) * 2009-05-28 2010-12-02 Aptapharma, Inc. Multilayer oral tablets containing a non-steroidal anti-inflammatory drug and/or acetaminophen
JP2012531430A (ja) * 2009-06-25 2012-12-10 ポーゼン インコーポレイテッド アスピリン療法を必要とする患者を治療するための方法
EA201290026A1 (ru) 2009-06-25 2012-07-30 Астразенека Аб Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid)
WO2011025673A1 (en) * 2009-08-26 2011-03-03 Aptapharma, Inc. Multilayer minitablets
EP2519229A2 (en) * 2009-12-29 2012-11-07 Novartis AG New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080500A2 (en) * 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080502A2 (en) * 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
US8563035B2 (en) 2010-05-05 2013-10-22 Sanovel Ilac Sanayi Ve Ticaret Anomin Sirketi Oral tablet compositions of dexlansoprazole
EP2384747A3 (en) * 2010-05-05 2012-01-18 Sanovel Ilac Sanayi ve Ticaret A.S. Oral Tablet Compositions Of Dexlansoprazole
EP2384746A3 (en) * 2010-05-05 2012-03-07 Sanovel Ilac Sanayi ve Ticaret A.S. Dual release oral tablet compositions of dexlansoprazole
TR201006225A1 (tr) * 2010-07-28 2012-02-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Çift salım sağlayan dekslansoprazol oral tablet bileşimleri
EP2384745A3 (en) * 2010-05-05 2012-01-18 Sanovel Ilac Sanayi ve Ticaret A.S. Modified release pharmaceutical compositions of dexlansoprazole
US20120164233A1 (en) * 2010-07-30 2012-06-28 Ranbaxy Laboratories Limited Pulsatile release pharmaceutical formulation of dexlansoprazole
KR101730865B1 (ko) 2011-02-11 2017-04-27 주식회사유한양행 레바프라잔-함유 나노입자를 포함하는 경구투여용 약학 조성물 및 그의 제조방법
WO2012111024A1 (en) * 2011-02-18 2012-08-23 Suven Nishtaa Pharma Pvt Ltd Pharmaceutical compositions of dexlansoprazole
EA028049B1 (ru) 2011-12-28 2017-10-31 Поузен Инк. Улучшенные композиции и способы доставки омепразола и ацетилсалициловой кислоты
KR101739820B1 (ko) * 2012-03-28 2017-05-25 주식회사유한양행 레바프라잔 또는 그의 염을 함유하는 비수성 액체 형태의 경구투여용 약학 조성물
UY39094A (es) * 2020-02-27 2021-07-30 Hk Inno N Corp Composición farmacéutica que comprende compuesto derivado de bencimidazol
AU2022381536A1 (en) 2021-11-05 2024-05-02 Cinclus Pharma Holding AB (publ) Polymorphs of the hydrochloride salt of linaprazan glurate

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
JP2896532B2 (ja) * 1994-08-13 1999-05-31 ユーハン コーポレーション 新規なピリミジン誘導体およびその製造方法
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) * 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
SE9600071D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
US6632451B2 (en) * 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
IL159129A0 (en) * 2001-06-01 2004-05-12 Pozen Inc PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs
US8206741B2 (en) * 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
SE0203065D0 (sv) * 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
JP4933033B2 (ja) * 2003-03-17 2012-05-16 武田薬品工業株式会社 放出制御組成物
US20060178348A1 (en) * 2005-01-24 2006-08-10 Pozen Inc. Compositions and therapeutic methods utilizing a combination of a protein extravasation inhibitor and an NSAID
US20060178349A1 (en) * 2005-01-24 2006-08-10 Pozen Inc. Compositions and therapeutic methods utilizing a combination of a 5-HT1F inhibitor and an NSAID

Similar Documents

Publication Publication Date Title
JP2008534438A5 (enExample)
CA2170644C (en) Multiple unit pharmaceutical preparation containing proton pump inhibitor
EP1078628B1 (en) Multiple unit tableted dosage form
EP2112920B1 (en) Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
CA2318008A1 (en) Solid oral pharmaceutical formulation of modified release that contains an acid labile benzimidazole compound
JP2009102335A (ja) 胃腸障害を処置するための剤形
CA2463690A1 (en) Granules containing acid-unstable chemical in large amount
US20050214372A1 (en) Stable pharmaceutical composition comprising an acid labile drug
RU2013106514A (ru) Способы лечения нарушений желудочно-кишечного тракта независимо от потребления пищи
CN103784414B (zh) 一种埃索美拉唑肠溶片及其制备方法
WO2007138022A3 (en) Lipoic acid pellets
RU2014122135A (ru) Фармацевтическая композиция омепразола
CN102600109B (zh) 一种右兰索拉唑迟释胶囊及其制备方法
CN110785164A (zh) 包括质子泵抑制剂的口服用固体制剂组合物、包括该组合物的口服用固体制剂及其制造方法
CN1243546C (zh) 不溶于胃液的微粒、其制备方法和药物制剂
RS53443B (sr) Dozni oblik koji sadrži pantoprazol kao aktivni sastojak
JP2008502740A (ja) ベンズイミダゾール化合物の安定医薬製剤
WO2007074910A1 (ja) 放出制御固形製剤
CA2470609A1 (en) Tableted oral pharmaceutical dosage form, with an enteric coating, containing a benzimidazole compound labile in an acid medium
DE102008045339A1 (de) Pharmazeutisches Pellet
CA2733299A1 (en) Oral pharmaceutical formulation for omeprazole comprising a specific separation layer
JP2006506367A5 (enExample)
CA2740974A1 (en) Dosage forms for the rapid and sustained elevation of gastric ph
WO2008018825A1 (en) Oral polyvinyl alcohol capsules comprising proton pump inhibitors
ES2466441T3 (es) Composiciones farmacéuticas que comprenden fármaco antiinflamatorio no esteroideo, acetaminofén e inhibidor de la bomba de protones